Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2007
08/07/2007US7252974 Human growth gene and short stature gene region
08/07/2007US7252819 Methods and compositions for correction of cardiac conduction disturbances
08/07/2007US7252654 Apparatus with weeping tip and method of use
08/07/2007CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties
08/07/2007CA2286304C Pca3, pca3 genes, and methods of use
08/07/2007CA2246568C Phosphatidyl oligoglycerols
08/07/2007CA2182388C Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
08/07/2007CA2132265C Anti-sense oligonucleotides against hsv-1, and their preparation
08/07/2007CA2062829C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses
08/02/2007WO2007087544A2 Novel compositions of chemically modified small interfering rna
08/02/2007WO2007087451A2 Compositions and methods for enhancing discriminatory rna interference
08/02/2007WO2007087415A2 Compositions and methods for inhibition leukocyte function
08/02/2007WO2007087412A2 Tat-036 and methods of assessing and treating cancer
08/02/2007WO2007087370A2 Tat-038 and methods of assessing and treating cancer
08/02/2007WO2007087367A2 Methods and compositions for modulating the mobilization of stem cells
08/02/2007WO2007087178A2 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same
08/02/2007WO2007087113A2 Natural antisense and non-coding rna transcripts as drug targets
08/02/2007WO2007086923A2 Controlled and sustained gene transfer mediated by thiol-modified polymers
08/02/2007WO2007086526A1 Gene polymorphism and use thereof
08/02/2007WO2007061627A3 Direct dna delivery to bone cells
08/02/2007WO2007057618A3 Inducible promoters
08/02/2007WO2006048017A8 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
08/02/2007WO2005096781A3 Methods and compositions for treating gain-of-function disorders using rna interference
08/02/2007US20070180545 TAT-031 and methods of assessing and treating cancer
08/02/2007US20070180544 Methods and compositions for autism spectrum disorders
08/02/2007US20070180543 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
08/02/2007US20070179113 GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
08/02/2007US20070179112 Polymeric nucleoside prodrugs
08/02/2007US20070179111 Methods of treating proteinuria by reducing double-stranded dna antibodies
08/02/2007US20070179110 Expression of immunogenic substances
08/02/2007US20070179109 Double strand compositions comprising differentially modified strands for use in gene modulation
08/02/2007US20070179108 Double strand compositions comprising differentially modified strands for use in gene modulation
08/02/2007US20070179107 Double strand compositions comprising differentially modified strands for use in gene modulation
08/02/2007US20070179106 Double strand compositions comprising differentially modified strands for use in gene modulation
08/02/2007US20070179105 Method and means for treating solid tumors
08/02/2007US20070179104 Moderator of gene expression of Winged helix nude; small nucleic acidsl alopecia; autoimmune disease
08/02/2007US20070179103 Immunostimulatory oligonucleotide multimers
08/02/2007US20070179102 Methods and compositions for the treatment and diagnosis of pain disorders using 9805, 2047, 46566, 57749, 577, 20739, 57145, 1465, 1587, 2146, 2207, 32838, 336 or 52908
08/02/2007US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents
08/02/2007US20070179100 Protected monomers
08/02/2007US20070179095 orally administering to a patient a therapeutically effective amount of factor VIII in water to induce oral tolerance and supply exogenous factor VIII ( not present in liposome), for increasing hemostasis in the patient having hemophilia A; obtained from milk of a non-human transgenic mammal
08/02/2007US20070179091 Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling
08/02/2007US20070179089 Structure of SOCS and uses thereof
08/02/2007US20070179087 Method for treating inflammatory diseases using heat shock proteins
08/02/2007US20070179083 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding
08/02/2007US20070178592 Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same
08/02/2007US20070178585 Eukaryotic cell overexpressing an endogenous gene; introducing a vector containing a transcriptional regulatory sequence into the cell, allowing the vector to integrate into the genome of the cell by non-homologous recombination
08/02/2007US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
08/02/2007US20070178553 Mammalian T-type calcium channels
08/02/2007US20070178114 Novel kallikrein gene
08/02/2007US20070178111 Identification and application of antibiotic synergy
08/02/2007US20070178110 Surface-located campylobacter jejuni polypeptides
08/02/2007US20070178108 Colon Specific Gene and Protein and Cancer
08/02/2007US20070178107 Method and means for treating solid tumors
08/02/2007US20070178105 FHIT proteins and nucleic acids and methods based thereon
08/02/2007US20070178104 Methods and means for treating solid tumors
08/02/2007US20070178087 Method for Treating Immune Dysfunction by Regulation of CD40 Ligand Expression
08/02/2007US20070178082 Stabilized single domain antibodies
08/02/2007US20070178077 Method for in vitro preconditioning of myoblasts before transplantation
08/02/2007US20070178076 Porous membrane device that promotes the differentiation of monocytes into dendritic cells
08/02/2007US20070178075 Side Population Cells in Cardiac Repair
08/02/2007US20070178071 Stem-cell, precursor cell, or target cell-based treatment of multiorgan failure and renal dysfunction
08/02/2007US20070178069 Herpes simplex virus vector
08/02/2007US20070178068 Compositions and methods for regulating complement system
08/02/2007US20070178067 System and method for cytological analysis by raman spectroscopic imaging
08/02/2007US20070178066 Pathotropic targeted gene delivery system for cancer and other disorders
08/02/2007US20070178065 Neutralizing factors as vaccine adjuvants
08/02/2007US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis)
08/02/2007CA2640087A1 Methods and compositions for modulating the mobilization of stem cells
08/02/2007CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same
08/02/2007CA2597724A1 Cationic lipids and formulated molecular compositions containing them
08/01/2007EP1813676A2 Retroviral vectors pseudotyped with influenza virus hemagglutin for gene delivery
08/01/2007EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby
08/01/2007EP1813289A1 Medicinal composition for treating cancer or diabetes
08/01/2007EP1812864A2 Multifunctional nanoparticles conjugates and their use
08/01/2007EP1812564A2 Defective influenza virus particles
08/01/2007EP1812560A1 Retina-specific cells differentiated in vitro from bone marrow stem cells, the production thereof and their use
08/01/2007EP1812077A2 Modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease
08/01/2007EP1812075A1 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
08/01/2007EP1556494B1 Bicistronic vector encoding a vegf and an fgf, use thereof
08/01/2007EP1507561A4 Compositions for delivering nucleic acids to cells
08/01/2007EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy
08/01/2007EP1082410B1 Human cd45+ and/or fibroblast + mesenchymal stem cells
08/01/2007EP0884947B1 Dna vaccination for induction of suppressive t cell response
08/01/2007CN1329513C Avian polynucleotide vaccine formula for anti pig's diseases
08/01/2007CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
08/01/2007CN1329409C Modulation of the expression of genes dependent on STAT-1
08/01/2007CN1329083C Method for degrading AML 1-ETO fusion protein and used reagent
08/01/2007CN101010073A Nanocoating for improving biocompatibility of medical implants
08/01/2007CN101007839A Nucleic acid molecule RTN4BSR12 and its application in preparing anticancer medicine
08/01/2007CN101007838A Nucleic acid molecule RTN4BSR22 and its application in preparing anticancer medicine
08/01/2007CN101007837A Nucleic acid molecule RTN4BSR42 and its application in preparing anticancer medicine
08/01/2007CN101007836A Nucleic acid molecule RTN4BSR52 and its application in preparing anticancer medicine
08/01/2007CN101007835A Nucleic acid molecule RTN4BSR5 and its application in preparing anticancer medicine
08/01/2007CN101007834A Nucleic acid molecule RTN4BSR4 and its application in preparing anticancer medicine
08/01/2007CN101007833A Nucleic acid molecule RTN4BSR3 and its application in preparing anticancer medicine
08/01/2007CN101007832A Nucleic acid molecule RTN4BSR2 and its application in preparing anticancer medicine
08/01/2007CN101007831A Nucleic acid molecule RTN4BSR1and its application in preparing anticancer medicine
08/01/2007CN101007027A Application method of neural regulation protein in the treatment of cardiovascular diseases and its composition
07/2007
07/31/2007US7250488 Transcriptional activation inhibitory protein